期刊文献+

1-磷酸鞘氨醇在心血管系统中作用的研究进展 被引量:6

Research Progress in Effect of Sphingosine 1-phosphate on Cardiovascular System
下载PDF
导出
摘要 1-磷酸鞘氨醇(S1P)是鞘磷脂代谢的中间产物之一。血浆中的S1P主要是以与脂蛋白结合的形式存在的。S1P主要有5种受体,在内皮细胞、血管平滑肌细胞及心肌细胞均有广泛表达。S1P主要通过与细胞表面的特定受体(S1PR)结合而发挥广泛的生物学效应,如血管内皮保护、抑制平滑肌细胞迁移、心肌缺血/再灌注损伤的保护、抑制黏附分子表达等。心血管系统的发育、动脉粥样硬化、心肌缺血/再灌注损伤等病理生理过程,均有S1P的参与。 Sphingosine1-phosphate(S1P) is one of the intermediate products of the metabolism of sphingomyelins.S1P mainly exists in lipoprotein-bound form in plasma.It has five kinds of specific receptors.They are widely expressed in endothelial cells,vascular smooth muscle cells and cardiac myocytes.Mainly through specific cell surface receptors(of S1P receptor,the combination of S1PR) S1P plays a wide range of biological effects,such as vascular endothelial protection,inhibition of smooth muscle cell migration,myocardial ischemia / reperfusion injury protection,and inhibition of the expression of adhesion molecules.The development of the cardiovascular system,the pathophysiological process of atherosclerosis and myocardial ischemia / reperfusion injury all involve the effects of S1P.
作者 景小东 佘强
出处 《医学综述》 2013年第15期2719-2721,共3页 Medical Recapitulate
关键词 1-磷酸鞘氨醇 心血管系统 动脉粥样硬化 心肌缺血 再灌注损伤 Sphingosine 1-phosphate Cardiovascular System Atherosclerosis Myocardial ischemia/reperfusion injury
  • 相关文献

参考文献25

  • 1Argraves KM,Gazzolo PJ,Groh EM,et al.High density lippprotein-associated shpingosine 1-phosphate promotes endothelial barrier function[J].J Biol Chem,2008,283(36):25074-25081.
  • 2Thilmeier G,Schmidt C,Herrmann J,et al.High-density lippproteins and their constituent,shpingosine-1-phosphate,directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysopholipid receptor[J].Circulation,2006,114(13):1403-1409.
  • 3Nofer JR,Bot M,Brodde M,et al.FTY720,a sunthetic shpingosine 1 phosphate analogue,inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice[J].Circulation,2007,115(4):501-508.
  • 4Li QF,Wu CT,Duan HF,et al.Activation of sphingosine kinase medates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis[J].Br J Haematol,2007,138(5):632-639.
  • 5Ohvera A,Eisner C,Kitamura Y,et al.Sphingosine kinase 1 and Sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice[J].J Clin Invest,2010,120(5):1429-1440.
  • 6ItoK,Anada Y,Tani M,et al.Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes[J].Biochem Biophys Res Commun,2007,357(1):212-217.
  • 7Pappu R,Schwab SR,Cornelissen I,et al.Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate[J].Science,2007,316(5822):295-298.
  • 8Murata N,Sato K,Kon J,et al.Interaction of sphingosine 1-phosphate with plasma components,including lipoproteins,regulates the lipid receptor-mediated actions[J].Biochem J,2000,352(Pt 3):809-815.
  • 9Jones PM,George AM.The ABC transporter structure and mechanism:perspectives on recent research[J].Cell Mol Life Sci,2004,61(6):682-699.
  • 10Rea PA,Li ZS,Lu YP,et al.From vacuol ar GS-X pumps to multispecific ABC transporters[J].Annu Rev Plant Physiol Plant Mol Biol,1998,49:727-760.

同被引文献59

  • 1邱雨美,尹史帝,董伟,梁永红,谢梦蝶,李洪铭,王惟可,汤喜兰.薯蓣皂苷对异丙肾上腺素诱导H9c2心肌细胞肥大的保护作用[J].中药药理与临床,2022,38(2):94-99. 被引量:2
  • 2程林辉,陈兰英,寿斌耀,罗颖颖,崔亚茹,刘荣华.基于网络药理学和实验验证交趾黄檀心材调控能量代谢治疗心肌缺血分子机制[J].中国中药杂志,2022,47(24):6696-6708. 被引量:4
  • 3Kim JH, Bae HY, Kim SY. Clinical marker of platelet hyperreactivity in diabetes mellitus [J]. Diabetes Metab J, 2013,37 (6) : 423-428.
  • 4Katsuma S, Hada Y, Ueda T, et al. Signalling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation [J]. Genes Cells, 2002,7(12) : 1217-1230.
  • 5Lan T, Bi H, Liu W, et al. Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography-tandem mass spectrometry [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2011,879 (7- 8) : 520-526.
  • 6Paneni F, Beckman JA, Creager MA, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I [J]. Eur Heart J, 2013,34(31): 2436-2443.
  • 7Zeng Z, Li YC, Jiao ZH, et al. The cross talk between eGMP signal pathway and PKC in pulmonary endothelial cell angiogenesis [Jl. Int J Mol Sei, 2014,15(6) : 10185-10198.
  • 8Sena CM, Pereira AM, Seia R. Endothelial dysfunction: a major mediator of diabetic vascular disease [ J ]. Bio- chim Biophys Acta, 2013, 1832(12) :2216-31.
  • 9Paneni F, Beckman JA, Creager MA, et al. Diabetes and vascular disease : pathophysiology, clinical consequences,and medical therapy: part I[J]. Eur Heart J, 2013, 34 (31) :2436-2443.
  • 10Knapp M, Zendzian-Piotrowska M, Blachnio-Zabielska A, et al. Myocardial infarction differentially alters sphingoli- pid levels in plasma, erythrocytes and platelets of the rat [J], Basic Res Cardiol, 2012, 107(6) :294.

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部